These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 8672709)

  • 1. Design considerations in crossover trials with a single interim analysis and serial patient entry.
    Cook RJ; Willan AR
    Biometrics; 1996 Jun; 52(2):732-9. PubMed ID: 8672709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interim analyses in 2 x 2 crossover trials.
    Cook RJ
    Biometrics; 1995 Sep; 51(3):932-45. PubMed ID: 7548709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of two-stage test statistic in the two-period crossover trials.
    Wang SJ; Hung HM
    Biometrics; 1997 Sep; 53(3):1081-91. PubMed ID: 9333341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comment on interim analyses in crossover trials.
    Grieve AP; Senn S
    Biometrics; 1996 Dec; 52(4):1515-20. PubMed ID: 9019232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal conditional error functions for the control of conditional power.
    Brannath W; Bauer P
    Biometrics; 2004 Sep; 60(3):715-23. PubMed ID: 15339294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increasing the sample size when the unblinded interim result is promising.
    Chen YH; DeMets DL; Lan KK
    Stat Med; 2004 Apr; 23(7):1023-38. PubMed ID: 15057876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A group-sequential design for clinical trials with treatment selection.
    Stallard N; Friede T
    Stat Med; 2008 Dec; 27(29):6209-27. PubMed ID: 18792085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bayesian design and analysis of two x two factorial clinical trials.
    Simon R; Freedman LS
    Biometrics; 1997 Jun; 53(2):456-64. PubMed ID: 9192445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and analysis of group sequential logrank tests in maximum duration versus information trials.
    Kim K; Boucher H; Tsiatis AA
    Biometrics; 1995 Sep; 51(3):988-1000. PubMed ID: 7548714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tests for the analysis of variance of crossover designs with correlated errors.
    Bellavance F; Tardif S; Stephens MA
    Biometrics; 1996 Jun; 52(2):607-12. PubMed ID: 8672705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interim analysis on survival data: its potential bias and how to repair it.
    van Houwelingen HC; van de Velde CJ; Stijnen T
    Stat Med; 2005 Sep; 24(18):2823-35. PubMed ID: 16025546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Group sequential tests for bivariate response: interim analyses of clinical trials with both efficacy and safety endpoints.
    Jennison C; Turnbull BW
    Biometrics; 1993 Sep; 49(3):741-52. PubMed ID: 8241370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multiple-step selection procedure with sequential protection of preferred treatments.
    Chen TT; Simon R
    Biometrics; 1993 Sep; 49(3):753-61. PubMed ID: 8241371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carryover and the two-period crossover clinical trial.
    Willan AR; Pater JL
    Biometrics; 1986 Sep; 42(3):593-9. PubMed ID: 3567292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementation of group sequential logrank tests in a maximum duration trial.
    Lan KK; Lachin JM
    Biometrics; 1990 Sep; 46(3):759-70. PubMed ID: 2242413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of two methods for adaptive interim analyses in clinical trials.
    Wassmer G
    Biometrics; 1998 Jun; 54(2):696-705. PubMed ID: 9629649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interim monitoring of longitudinal comparative studies with recurrent event responses.
    Cook RJ; Lawless JF
    Biometrics; 1996 Dec; 52(4):1311-23. PubMed ID: 8962455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interim analysis for randomized clinical trials: simulating the predictive distribution of the log-rank test statistic.
    Chang MN; Shuster JJ
    Biometrics; 1994 Sep; 50(3):827-33. PubMed ID: 7981402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sample size re-estimation in group-sequential response-adaptive clinical trials.
    Morgan CC
    Stat Med; 2003 Dec; 22(24):3843-57. PubMed ID: 14673942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using the maximum test statistic in the two-period crossover clinical trial.
    Willan AR
    Biometrics; 1988 Mar; 44(1):211-8. PubMed ID: 3358989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.